Curonz

Q: What is Curonz's official website?

Curonz's official website is www.curonz.com

Q: What is Curonz's Revenue?

Curonz's revenue is <$5 Million

Q: What industry does Curonz belong to?

Curonz is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What technology does Curonz use?

Some of the popular technologies that Curonz uses are: Plesk, Microsoft 365, Crazy Domains DNS Hosting, Sectigo

Q: How do I contact Curonz?

Curonz contact info: Phone number: +64 21500453 Website: www.curonz.com

Q: What does Curonz do?

Curonz Limited is a clinical stage Neurotherapeutics company focused on improving the quality of life for severely neurologically affected children and adults. They develop a drug therapy using a modified molecule, NRP2945, which effectively controls seizure activity and improves comorbidities in patients with conditions like Lennox-Gastaut Syndrom... e and drug-resistant Temporal Lobe Epilepsy. The company emphasizes the minimal adverse effects of their peptide drug, which is administered via subcutaneous injections. Curonz has successfully completed Phase I and small Phase II clinical trials, demonstrating the safety and efficacy of their treatment approach. Read More

Q: What are Curonz social media links?

Curonz Linkedin page Curonz Twitter page

Q: Is Curonz a public company?

Curonz is private company therefore does not currently have an official ticker symbol

Manufacturing · New Zealand · 1-10 Employees

View Company Info for Free

Overview

Headquarters

29 Nugent St, Auckland, Auckland, 1150, ...

Phone Number

+64 21500453

Website

www.curonz.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

ZI Rank: 1

Signal Type

Dec

Jan

Feb

Mar

Apr

May

ZI Rank

About Curonz

Curonz Limited is a clinical stage Neurotherapeutics company focused on improving the quality of life for severely neurologically affected children and adults. They develop a drug therapy using a modified molecule, NRP2945, which effectively controls seizure activity and improves comorbidities in patients with conditions like Lennox-Gastaut Syndrome and drug-resistant Temporal Lobe Epilepsy. The company emphasizes the minimal adverse effects of their peptide drug, which is administered via subcutaneous injections. Curonz has successfully completed Phase I and small Phase II clinical trials, demonstrating the safety and efficacy of their treatment approach.Explore more

Is this data correct?

View contact profiles from Curonz

Popular SearchesCuronz LtdCuronzSIC Code 28,283NAICS Code 32,325Show more

Curonz Org Chart

Phone

Kevin Sullivan

Chief Legal Officer & Director

Phone

Get the full picture

Jane Calvert

Patent Lawyer, Director

Phone

Get the full picture

Is Curonz your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Funding: Get notified immidiatlly once Curonz has new funding data

Earning: See what the market has to say on Curonz recently announced quarterly report

Check out if Curonz is spiking on competitors!

Website visits: Recent activity has been detected on your website

Curonz, which may be a good buyer, showed buying intent in Masked Content Topic

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Click to see if Curonz had a recent Job posting/layoffs

Check if Curonz has recently received funding, and reach out quickly before it becomes old news!

Congratulate Masked Content for being promoted to Masked Content at Curonz

Product Launch: Get notified when Curonz launches new products

Recommended Actions

Reach out to Masked Content who joined Curonz as Masked Content

Find 3 more new buyers

View Email Formats for Curonz

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Curonz is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Curonz is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Curonz.